BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27287779)

  • 1. A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL).
    Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Buono DL; Nathanson SD; Bovbjerg DH; Mandelblatt JS; Tsai WY; Jacobson JS; Hershman DL
    Breast Cancer Res Treat; 2016 Jul; 158(1):127-138. PubMed ID: 27287779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy.
    Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL
    Breast J; 2012; 18(3):203-13. PubMed ID: 22487337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer.
    Richardson LC; Wang W; Hartzema AG; Wagner S
    Breast J; 2007; 13(6):581-7. PubMed ID: 17983400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status.
    Farias AJ; Du XL
    Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1266-1275. PubMed ID: 28515111
    [No Abstract]   [Full Text] [Related]  

  • 5. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study.
    Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Leoce N; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL
    J Clin Oncol; 2012 Nov; 30(31):3800-9. PubMed ID: 23008305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL).
    Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Leoce N; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL
    Breast Cancer Res Treat; 2012 Jul; 134(1):419-28. PubMed ID: 22527111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL).
    Hershman DL; Kushi LH; Hillyer GC; Coromilas E; Buono D; Lamerato L; Bovbjerg DH; Mandelblatt JS; Tsai WY; Zhong X; Jacobson JS; Wright JD; Neugut AI
    Breast Cancer Res Treat; 2016 May; 157(1):133-43. PubMed ID: 27086286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
    Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL
    JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Sarcopenia With Toxicity-Related Discontinuation of Adjuvant Endocrine Therapy in Women With Early-Stage Hormone Receptor-Positive Breast Cancer.
    Saraf A; Tahir I; Hu B; Dietrich AW; Tonnesen PE; Sharp GC; Tillman G; Roeland EJ; Nipp RD; Comander A; Peppercorn J; Fintelmann FJ; Jimenez RB
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):94-103. PubMed ID: 37506979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxanes for adjuvant treatment of early breast cancer.
    Willson ML; Burke L; Ferguson T; Ghersi D; Nowak AK; Wilcken N
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD004421. PubMed ID: 31476253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.
    Hoon SN; Lau PK; White AM; Bulsara MK; Banks PD; Redfern AD
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011220. PubMed ID: 34037241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Febrile neutropaenia and chemotherapy discontinuation in women aged 70 years or older receiving adjuvant chemotherapy for early breast cancer.
    Adjogatse D; Thanopoulou E; Okines A; Thillai K; Tasker F; Johnston SR; Harper-Wynne C; Torrisi E; Ring A
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):692-6. PubMed ID: 24909701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.
    Balazard F; Bertaut A; Bordet É; Mulard S; Blanc J; Briot N; Paux G; Dhaini Merimeche A; Rigal O; Coutant C; Fournier M; Jouannaud C; Soulie P; Lerebours F; Cottu PH; Tredan O; Vanlemmens L; Levy C; Mouret-Reynier MA; Campone M; Brady KJS; Sasane M; Rice M; Coulouvrat C; Martin AL; Jacquet A; Vaz-Luis I; Herold C; Pistilli B
    J Natl Cancer Inst; 2023 Sep; 115(9):1099-1108. PubMed ID: 37434306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to adjuvant endocrine therapy: is it a factor for ethnic differences in breast cancer outcomes in New Zealand?
    Seneviratne S; Campbell I; Scott N; Kuper-Hommel M; Kim B; Pillai A; Lawrenson R
    Breast; 2015 Feb; 24(1):62-7. PubMed ID: 25486877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer.
    Reyes SA; King TA; Fei K; Franco R; Bickell NA
    Ann Surg Oncol; 2016 May; 23(5):1537-42. PubMed ID: 26714953
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.